The Decision of the General Council of the WTO of 30 August 2003 spells out the circumstances under which countries without pharmaceutical manufacturing capacity can import generic versions of drugs still under patent.
The Decision of the General Council of the WTO of 30 August 2003 spells out the circumstances under which countries without pharmaceutical manufacturing capacity can import generic versions of drugs still under patent.